Fierce Pharma Biopharma News & Insights
5 天之前 · Fierce Pharma delivers breaking news and analysis about drug companies, the FDA and the broader pharma industry, including manufacturing, marketing and finance.
Top 20 pharma companies by 2023 revenue - Fierce Pharma
There were changes at the top and the bottom of last year’s top 20 pharma rankings by revenue. And, in between, Novo Nordisk made a significant leap, jumping five spots propelled by …
Gilead’s Kite shortens Yescarta manufacturing time with FDA nod
2024年1月30日 · The manufacturing upgrade comes as Kite works through an important launch for Yescarta as a second-line therapy for large B-cell lymphoma. Last month, the FDA allowed …
Teva launches first U.S. generic Cialis as Eli Lilly braces for loss of ...
2018年9月28日 · The loss of Cialis comes during a major time of transformation for Lilly. During its second-quarter earnings report in July, the company announced that it will spin off its …
The top 10 generic drug makers by 2021 revenue - Fierce Pharma
Many producers of generic drugs have struggled to achieve growth in recent years due to pricing pressures. But there are promising signs that the industry is ready for an uptick, and they were ...
The top 10 most profitable pharma companies in 2021
The six largest drugmakers by 2021 revenue—J&J, Pfizer, Roche, AbbVie, Novartis and Merck & Co.—all made the top profit list but in quite a different order.
Pharma | Fierce Pharma
Patients with the blood pressure condition have noted “difficulties and barriers in navigating the healthcare system.”
FDA signs off on Regeneron and Sanofi's Dupixent for COPD
2024年9月27日 · The companies began testing Dupixent in COPD in 2018, taking a risk by going straight to phase 3. When interim results for the BOREAS trial were positive, Sanofi kicked off …
The top 10 vaccine companies worldwide - Fierce Pharma
What a difference five years—and a global pandemic—can make in reshaping an industry. When Fierce Pharma last published our rankings of the top vaccine players back in 2017, we …
AstraZeneca's 3-in-1 COPD inhaler Breztri gets FDA green light to …
2020年7月24日 · But the British pharma immediately resorted to results from a second phase 3 program, dubbed Ethos, for its second try. According to detailed data recently published in The …